Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation

被引：51

作者：

Rotter, M ^{[1
]}

Jaïs, P ^{[1
]}

Vergnes, MC ^{[1
]}

Nurden, P ^{[1
]}

Takahashi, Y ^{[1
]}

Sanders, P ^{[1
]}

Rostock, T ^{[1
]}

Hocini, M ^{[1
]}

Sacher, F ^{[1
]}

Haïssaguerre, M ^{[1
]}

机构：

[1] Hop Cardiol Haut Leveque, Serv Rythmol, F-33604 Bordeaux, France

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 06期

关键词：

D O I：

10.1016/j.jacc.2005.12.038

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1231 / 1233

页数：3

共 11 条

[1] Inflammation as a risk factor for atrial fibrillation [J].

Aviles, RJ ;

Martin, DO ;

Apperson-Hansen, C ;

Houghtaling, PL ;

Rautaharju, P ;

Kronmal, RA ;

Tracy, RP ;

Van Wagoner, DR ;

Psaty, BM ;

Lauer, MS ;

Chung, MK .

CIRCULATION, 2003, 108 (24) :3006-3010

[2] C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation [J].

Chung, MK ;

Martin, DO ;

Sprecher, D ;

Wazni, O ;

Kanderian, A ;

Carnes, CA ;

Bauer, JA ;

Tchou, PJ ;

Niebauer, MJ ;

Natale, A ;

Van Wagoner, DR .

CIRCULATION, 2001, 104 (24) :2886-2891

[3] Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation [J].

Conway, DSG ;

Pearce, LA ;

Chin, BSP ;

Hart, RG ;

Lip, GYH .

CIRCULATION, 2003, 107 (25) :3141-3145

[4] Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome [J].

Haïssaguerre, M ;

Sanders, P ;

Hocini, M ;

Hsu, LF ;

Shah, DC ;

Scavée, C ;

Takahashi, Y ;

Rotter, M ;

Pasquié, JL ;

Garrigue, S ;

Clémenty, J ;

Jaïs, P .

CIRCULATION, 2004, 109 (24) :3007-3013

[5] Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation [J].

Kumagai, K ;

Nakashima, H ;

Urata, H ;

Gondo, N ;

Arakawa, K ;

Saku, K .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2197-2204

[6] Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation [J].

L'Allier, PL ;

Ducharme, A ;

Keller, PF ;

Yu, H ;

Guertin, MC ;

Tardif, JC .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (01) :159-164

[7] Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation - Effects of cardioversion and return of left atrial function [J].

Li-Saw-Hee, FL ;

Blann, AD ;

Gurney, D ;

Lip, GYH .

EUROPEAN HEART JOURNAL, 2001, 22 (18) :1741-1747

[8] Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation [J].

Nakano, Y ;

Niida, S ;

Dote, K ;

Takenaka, S ;

Hirao, H ;

Miura, F ;

Ishida, M ;

Shingu, T ;

Sueda, T ;

Yoshizumi, M ;

Chayama, K .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) :818-825

[9] Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation [J].

Psychari, SN ;

Apostolou, TS ;

Sinos, L ;

Hamodraka, E ;

Liakos, G ;

Kremastinos, DT .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (06) :764-767

[10] Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation [J].

Thambidorai, SK ;

Parakh, K ;

Martin, DO ;

Shah, TK ;

Wazni, O ;

Jasper, SE ;

Van Wagoner, DR ;

Chung, MK ;

Murray, RD ;

Klein, AL .

AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (06) :805-807

← 1 2 →